PI-3065,
955977-50-1,
PI3065,
PI 3065,
4-(6-((4-(cyclopropylmethyl)piperazin-1-yl)methyl)-2-(5-fluoro-1H-indol-4-yl)thieno[3,2-d]pyrimidin-4-yl)morpholine,
4-[6-[[4-(cyclopropylmethyl)piperazin-1-yl]methyl]-2-(5-fluoro-1H-indol-4-yl)thieno[3,2-d]pyrimidin-4-yl]morpholine,
6-[[4-(Cyclopropylmethyl)-1-piperazinyl]methyl]-2-(5-fluoro-1H-indol-4-yl)-4-(4-morpholinyl)-thieno[3,2-d]pyrimidine,
GTPL8242,
SCHEMBL2468696,
KS-00001CWS,
EX-A531,
AOB87791,
BCP12801,
MFCD28167771,
s7623,
AKOS025404833,
ZINC144899724,
CS-3100,
LM-3414,
PI-3065|PI3065,
NCGC00386429-03,
6-(4-cyclopropylmethyl-piperazin-1-ylmethyl)-2-(5-fluoro-1h-indol-4-yl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine,
AC-30278,
AK174780,
BC600621,
DA-40130,
HY-12235,
QC-11759,
FT-0700421,
A14338,
J-690408,
4-(6-((4-(cyclopropylmethyl)piperazin-1-yl)methyl)-2-(5-fluoro-1H-indol-4-yl)thieno[3,2,
D01SSI,
CYCLODODECANE EPOXIDE,
-d]pyrimidin-4-yl)morpholine,
YDNOHCOYQVZOMC-UHFFFAOYSA-N,
6-((4-(cyclopropylmethyl)piperazin-1-yl)methyl)-2-(5-fluoro-1H-indol-4-yl)-4-morpholinothieno[3,2-d]pyrimidine,